Johnson J.A., Evans W.E. “Molecular Diagnostics as a Predictive
Tool: Genetics of Drug Efficacy and Toxicity.” (Invited review)
Trends Mol. Med., 8:300-305 (2002).
Evans W.E., Johnson J.A. “Pharmacogenomics: The Inherited Basis
for Inter-individual Differences in Drug Response.” (Invited review)
Ann. Rev. Genomics Hum. Genet., 2:9-39 (2001).
Wang J., Humma L.M., Mougey E.B., David C.J., Johnson J.A., Lima J.J.,
Sylvester J.E. “Determination of Human b2-adrenergic Receptor Haplotypes
by Denaturation Selective Amplification and Subtractive Genotyping.”
Am. J. Pharmacogenom, 1:315-322 (2001).
Humma L.M., Puckett B.J., Richardson H.E., Terra S.G., Andrisin T.E.,
Lejeune B.L., Farmerie W.G., Wallace M.R., Lewis J.F., McNamara D.M., Picoult-Newberg
L., Pepine C.J., Johnson J.A. “Effects of b1-adrenoceptor Genetic
Polymorphisms on Resting Hemodynamics in Patients Undergoing Diagnostic
Testing for Ischemia.” Am. J. Cardiol, 88:1034-37 (2001).
Johnson J.A. “Drug Target Pharmacogenomics: An Overview.”
(Invited review). Am. J. Pharmacogenomics, 1:271-281 (2001).